Compounds > cefuroxime
Page last updated: 2024-10-24

cefuroxime and Anemia, Hemolytic

cefuroxime has been researched along with Anemia, Hemolytic in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malloy, CA1
Kiss, JE1
Challapalli, M1
Barton, LL1

Other Studies

2 other studies available for cefuroxime and Anemia, Hemolytic

ArticleYear
Cefuroxime-induced immune hemolysis.
    The Journal of pediatrics, 2003, Volume: 143, Issue:1

    Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antibodies, Anti-Idiotypic; Cefuroxime; Child, Preschool;

2003
Cefuroxime-induced immune hemolysis.
    The Journal of pediatrics, 2004, Volume: 144, Issue:5

    Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Cefuroxime; Drug Hypersensitivity; Humans; Pneumonia, Bact

2004